Search results for

The multi-platinum-selling indie pop band is using research to inspire fans to take immediate action against climate change.

Community college is often touted as an affordable start for students who want to earn bachelor's degrees. But according to federal data, only 13% of students actually reach that goal.

President Biden's Democratic convention speech is expected to build a bridge to Vice President Harris. NPR's Leila Fadel talks to ex-White House chief of staff and Biden confidante Ron Klain.

A centrist human rights lawyer with working class roots, Keir Starmer is poised to be the first Labour leader to win a U.K. election in nearly 20 years.

The financial cards are stacked against many renters who survive hurricanes, floods, wildfires and other major weather disasters. The long-term effects can be devastating.

There are roughly 100 large wildfires burning in the western U.S., including one of the largest in California history. Why so many? Scientists point to climate change and firefighting policies.

Even when patients double-check that their care is covered by insurance, health providers may send them bills as they haggle with insurers over reimbursement. It's stressful and annoying — but legal.

Brexit was supposed to give Britain a handle on its borders, according to its boosters. But as the U.K. government still struggles with migration across the English Channel, migrants remain a high concern for many voters.

A proposed lithium mine in Serbia is spurring protests over its potential impact on the environment. The mineral is in high demand because it’s crucial for the batteries that run electric vehicles.

A federal judge has temporarily paused a Biden administration program that offers some immigrant spouses of U.S. citizens a path to citizenship without having to leave the country first.

The drug companies behind blockbuster weight loss and diabetes treatments have signaled that supply problems could soon be over, but many patients still have trouble getting the medicines.

The London-based rights group says the Israeli government is deliberately trying to annex the Palestinian territory.

Cheaper versions of Wegovy and Zepbound touted on social media could be fleeting. Copies are legal now because the brand-name drugs are in short supply. But the drugmakers are boosting production.

Younger generations are reshaping romantic norms. Futurist Jake Dunagan offers a glimpse into how things might look in the future.

Aid groups that help families get a sick or injured child to another country for care say obtaining approval from Israel for the child and an adult companion to leave has become intensely difficult.

The first night of the Democrat's convention is in the books. Police arrest protesters outside the convention. Secretary of State Blinken is due in Egypt and Qatar for Gaza cease-fire talks.

Robert Caro's "The Power Broker" was published 50 years ago this month. We meet the author, and learn why he delves so deep in his research.

Drug manufacturers have declared obesity drugs to be "available,” but patients are still struggling to fill prescriptions.

NPR's Scott Simon Speaks to Democratic strategist and chair of the Democratic National Convention Committee Minyon Moore, about the upcoming convention in Chicago.

Problems caused by the attack included delayed or lost lab results, medication errors, and an absence of routine safety checks to prevent potentially fatal mistakes, doctors and nurses told reporters.

NPR's A Martinez asks Georgia state Representative Ruwa Romman about balancing support for Vice President Harris and opposing the administration's policy toward the war in Gaza.

Arkansas is the only holdout state that has not pursued the Biden administration's offer to extend Medicaid coverage to new moms for a year after they give birth.

An evangelical Christian men’s group is trying to make a comeback with a new, more explicitly political agenda.

The congressional redistricting fights that President Trump sparked in Texas, California and other states have led some advocacy groups to reconsider their strategies against partisan gerrymandering.

Dylan O'Brien and James Sweeney craft a kind of chemistry that is equal parts funny and heart-wrenching.